What is Arbor Biotechnologies worth?
$238.9Mlast known valuation
Arbor Biotechnologies last raised $215.0M in its Later Stage VC (Oct 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Arbor Biotechnologies
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2021 | Later Stage VC | $215.0M | ▮ | ▮ |
| May 2017 | Early Stage VC | $15.6M | ▮ | ▮ |
How Arbor Biotechnologies's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Arbor Biotechnologies, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Arbor Biotechnologies worth?
- Arbor Biotechnologies's last known valuation is $238.9M.
- How much has Arbor Biotechnologies raised?
- Arbor Biotechnologies has raised $304.5M in total funding across 2 recorded rounds.
- When did Arbor Biotechnologies last raise?
- Arbor Biotechnologies last raised in Oct 2021 (Later Stage VC), raising $215.0M.